{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:43:09Z","timestamp":1790750589410,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"am","delay-in-days":212,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajem.2021.03.056","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T12:34:16Z","timestamp":1616589256000},"page":"154-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal"],"prefix":"10.1016","volume":"47","author":[{"given":"Austin S.","family":"Kilaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanmarie","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kit","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary F.","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.03.056_bb0005","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.ajem.2021.03.056_bb0010","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.2018.4867","article-title":"Increasing naloxone awareness and use: the role of health care practitioners","volume":"319","author":"Adams","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.03.056_bb0015","series-title":"Evidence-based Strategies for Preventing Opioid Overdose","author":"Carroll","year":"2018"},{"key":"10.1016\/j.ajem.2021.03.056_bb0020","author":"United States Food and Drug Administration"},{"key":"10.1016\/j.ajem.2021.03.056_bb0025","author":"American College of Emergency Physicians"},{"issue":"1","key":"10.1016\/j.ajem.2021.03.056_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Ann. Emerg. Med."},{"issue":"2","key":"10.1016\/j.ajem.2021.03.056_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/acem.13545","article-title":"Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program","volume":"26","author":"Samuels","year":"2019","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.03.056_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.annemergmed.2018.08.439","article-title":"A quality framework for emergency department treatment of opioid use disorder","volume":"73","author":"Samuels","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2021.03.056_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3209","article-title":"Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose","volume":"2","author":"Follman","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajem.2021.03.056_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11606-019-05423-7","article-title":"Association of opioid overdose risk factors and naloxone prescribing in US adults","volume":"35","author":"Lin","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ajem.2021.03.056_bb0055","author":"Centers for Medicare and Medicaid Services"},{"issue":"13","key":"10.1016\/j.ajem.2021.03.056_bb0060","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jama.2019.1954","article-title":"Marginal effects-quantifying the effect of changes in risk factors in logistic regression models","volume":"321","author":"Norton","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajem.2021.03.056_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.2018.6971","article-title":"Odds ratios-current best practice and use","volume":"320","author":"Norton","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.03.056_bb0070","first-page":"1","article-title":"Local health departments and the implementation of evidence-based policies to address opioid overdose mortality","author":"Feuerstein-Simon","year":"2020","journal-title":"Subst Abus"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721002448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721002448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:49Z","timestamp":1760025229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721002448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":14,"alternative-id":["S0735675721002448"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.03.056","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}